FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386407675> ?p ?o ?g. }

• W4386407675 abstract "EpigenomicsAhead of Print EditorialEpigenetics and companion diagnostics: opportunities and challengesDesislava K Tsoneva & Manlio VinciguerraDesislava K Tsoneva https://orcid.org/0000-0002-8141-2482Department of Medical Genetics, Medical University of Varna, 55 Marin Drinov str., Varna, BulgariaDepartment of Translational Stem Cell Biology, Research Institute of the Medical University, 55 Marin Drinov str., Varna, BulgariaSearch for more papers by this author & Manlio Vinciguerra *Author for correspondence: E-mail Address: manlio.vinciguerra@mu-varna.bghttps://orcid.org/0000-0002-1768-3894Department of Translational Stem Cell Biology, Research Institute of the Medical University, 55 Marin Drinov str., Varna, BulgariaSearch for more papers by this authorPublished Online:4 Sep 2023https://doi.org/10.2217/epi-2023-0203AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: companion diagnosticsepigeneticsnononcological diseasesoncological diseasesReferences1. Feinberg AP. The key role of epigenetics in human disease prevention and mitigation. N. Engl. J. Med. 378(14), 1323–1334 (2018).Crossref, Medline, CAS, Google Scholar2. Tordini F, Aldinucci M, Milanesi L, Liò P, Merelli I. The genome conformation as an integrator of multi-omic data: the example of damage spreading in cancer. Front. Genet. 7 (2016). http://journal.frontiersin.org/article/10.3389/fgene.2016.00194/fullGoogle Scholar3. Jørgensen JT. Companion and complementary diagnostics: clinical and regulatory perspectives. Trends Cancer 2(12), 706–712 (2016).Crossref, Google Scholar4. Tsoneva DK, Ivanov MN, Conev NV, Manev R, Stoyanov DS, Vinciguerra M. Circulating histones to detect and monitor the progression of cancer. Int. J. Mol. Sci. 24(2), 942 (2023).Crossref, CAS, Google Scholar5. Neel DS, Bivona TG. Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma. NPJ Precis. Oncol. 1(1), 3 (2017).Crossref, Google Scholar6. Lo YMD, Corbetta N, Chamberlain PF et al. Presence of fetal DNA in maternal plasma and serum. Lancet 350(9076), 485–487 (1997).Crossref, Medline, CAS, Google Scholar7. Allard WJ, Terstappen LWMM. CCR 20th anniversary commentary: paving the way for circulating tumor cells. Clin. Cancer Res. 21(13), 2883–2885 (2015).Crossref, Google Scholar8. Pantel K, Alix-Panabières C. Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol. Med. 16(9), 398–406 (2010).Crossref, Medline, Google Scholar9. Snyder MW, Kircher M, Hill AJ, Daza RM, Shendure J. Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin. Cell 164(1–2), 57–68 (2016).Crossref, Medline, CAS, Google Scholar10. Achour B, Gosselin P, Terrier J et al. Liquid biopsy for patient characterization in cardiovascular disease: verification against markers of cytochrome P450 and P‐glycoprotein activities. Clin. Pharm. Ther. 111(6), 1268–1277 (2022).Crossref, CAS, Google Scholar11. Benincasa G, Mansueto G, Napoli C. Fluid-based assays and precision medicine of cardiovascular diseases: the ‘hope’ for Pandora's box? J. Clin. Pathol. 72(12), 785–799 (2019).Crossref, CAS, Google Scholar12. Gaitsch H, Franklin RJM, Reich DS. Cell-free DNA-based liquid biopsies in neurology. Brain 146(5), 1758–1774 (2023).Crossref, Google Scholar13. Buzova D, Maugeri A, Liguori A et al. Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD). Clin. Epigenet. 12(1), 126 (2020).Crossref, CAS, Google Scholar14. Buzova D, Braghini MR, Bianco SD et al. Profiling of cell‐free DNA methylation and histone signatures in pediatric NAFLD: a pilot study. Hepatol. Commun. 6(12), 3311–3323 (2022).Crossref, CAS, Google Scholar15. US FDA. List of cleared or approved companion diagnostic devices (in vitro and imaging tools) (2023). www.fda.gov/medical-devices/in-vitro-diagnostics/list-cleared-or-approved-companion-diagnostic-devices-in-vitro-and-imaging-toolsGoogle Scholar16. Ltd Research and Markets. Companion diagnostics: technologies and markets (2023). www.researchandmarkets.com/reports/5416606/companion-diagnostics-technologies-and-marketsGoogle Scholar17. Ltd Research and Markets. Global aspirin market–forecasts from 2022 to 2027 (2022). www.researchandmarkets.com/reports/5649095/global-aspirin-market-forecasts-from-2022-toGoogle Scholar18. Maliepaard M, Nibi P, Nibi G, Pasmooij AMG. Evaluation of companion diagnostics in scientific advice and drug marketing authorization applications by the European Medicines Agency. Front. Med. 9, 893028 (2022).Crossref, Google Scholar19. Orellana García LP, Ehmann F, Hines PA, Ritzhaupt A, Brand A. Biomarker and companion diagnostics–a review of medicinal products approved by the European Medicines Agency. Front. Med. 8, 753187 (2021).Crossref, Google Scholar20. EMA. Guidance on the procedural aspects for the consultation to the European Medicines Agency by a notified body on companion diagnostics (2022). www.ema.europa.eu/en/documents/scientific-guideline/guidance-procedural-aspects-consultation-european-medicines-agency-notified-body-companion_en.pdf.Google Scholar21. Agarwal A, Snyder G, Ressler D. The current and future state of companion diagnostics. PGPM 8, 99–110 (2015).Crossref, Google Scholar22. Tanaka A, Suzuki H, Toyoshima S, Nagai N. Co-development of oncology drugs and companion diagnostics: analyses of approval lags and drug development periods in recently approved cases in Japan. Ther. Innov. Regul. Sci. 56(1), 85–95 (2022).Crossref, Google Scholar23. Fridlyand J, Simon RM, Walrath JC et al. Considerations for the successful co-development of targeted cancer therapies and companion diagnostics. Nat. Rev. Drug. Discov. 12(10), 743–755 (2013).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetails Ahead of Print STAY CONNECTED Metrics Downloaded 0 times History Received 6 June 2023 Accepted 16 August 2023 Published online 4 September 2023 Information© 2023 Future Medicine LtdKeywordscompanion diagnosticsepigeneticsnononcological diseasesoncological diseasesFinancial & competing interests disclosureThe authors are funded by the Ministry of Education and Science of Bulgaria under the National Scientific Programme “Excellent Research and People for the Development of European Science” 2021 (VIHREN) of the Bulgarian National Science Fund, contract #KP-06-DV/4 from 12/15/2021; by the Bulgarian National Science Fund, contract #KP-06-N53/6 from 11/11/2021. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download" @default.
• W4386407675 created "2023-09-05" @default.
• W4386407675 creator A5060095183 @default.
• W4386407675 creator A5069528663 @default.
• W4386407675 date "2023-09-04" @default.
• W4386407675 modified "2023-10-18" @default.
• W4386407675 title "Epigenetics and companion diagnostics: opportunities and challenges" @default.
• W4386407675 cites W1982760718 @default.
• W4386407675 cites W2058927281 @default.
• W4386407675 cites W2097395369 @default.
• W4386407675 cites W2100977485 @default.
• W4386407675 cites W2139172108 @default.
• W4386407675 cites W2239118478 @default.
• W4386407675 cites W2557558426 @default.
• W4386407675 cites W2592643813 @default.
• W4386407675 cites W2796298565 @default.
• W4386407675 cites W2979710768 @default.
• W4386407675 cites W3052645357 @default.
• W4386407675 cites W3195119838 @default.
• W4386407675 cites W3209418464 @default.
• W4386407675 cites W4220722277 @default.
• W4386407675 cites W4229032294 @default.
• W4386407675 cites W4306911966 @default.
• W4386407675 cites W4309508076 @default.
• W4386407675 cites W4313583536 @default.
• W4386407675 doi "https://doi.org/10.2217/epi-2023-0203" @default.
• W4386407675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37661843" @default.
• W4386407675 hasPublicationYear "2023" @default.
• W4386407675 type Work @default.
• W4386407675 citedByCount "0" @default.
• W4386407675 crossrefType "journal-article" @default.
• W4386407675 hasAuthorship W4386407675A5060095183 @default.
• W4386407675 hasAuthorship W4386407675A5069528663 @default.
• W4386407675 hasConcept C104317684 @default.
• W4386407675 hasConcept C161191863 @default.
• W4386407675 hasConcept C41008148 @default.
• W4386407675 hasConcept C41091548 @default.
• W4386407675 hasConcept C54355233 @default.
• W4386407675 hasConcept C60644358 @default.
• W4386407675 hasConcept C70721500 @default.
• W4386407675 hasConcept C71924100 @default.
• W4386407675 hasConcept C86803240 @default.
• W4386407675 hasConceptScore W4386407675C104317684 @default.
• W4386407675 hasConceptScore W4386407675C161191863 @default.
• W4386407675 hasConceptScore W4386407675C41008148 @default.
• W4386407675 hasConceptScore W4386407675C41091548 @default.
• W4386407675 hasConceptScore W4386407675C54355233 @default.
• W4386407675 hasConceptScore W4386407675C60644358 @default.
• W4386407675 hasConceptScore W4386407675C70721500 @default.
• W4386407675 hasConceptScore W4386407675C71924100 @default.
• W4386407675 hasConceptScore W4386407675C86803240 @default.
• W4386407675 hasFunder F4320321843 @default.
• W4386407675 hasLocation W43864076751 @default.
• W4386407675 hasLocation W43864076752 @default.
• W4386407675 hasOpenAccess W4386407675 @default.
• W4386407675 hasPrimaryLocation W43864076751 @default.
• W4386407675 hasRelatedWork W2014521477 @default.
• W4386407675 hasRelatedWork W2025898521 @default.
• W4386407675 hasRelatedWork W2049790344 @default.
• W4386407675 hasRelatedWork W2139503176 @default.
• W4386407675 hasRelatedWork W2154925273 @default.
• W4386407675 hasRelatedWork W2325121857 @default.
• W4386407675 hasRelatedWork W2796195916 @default.
• W4386407675 hasRelatedWork W2812842313 @default.
• W4386407675 hasRelatedWork W2979314934 @default.
• W4386407675 hasRelatedWork W4310701073 @default.
• W4386407675 isParatext "false" @default.
• W4386407675 isRetracted "false" @default.
• W4386407675 workType "article" @default.